Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
This study has been completed.
Sponsor:
O & O Alpan LLC
Collaborator:
Genentech
Information provided by (Responsible Party):
O & O Alpan LLC
ClinicalTrials.gov Identifier:
NCT01040598
First received: December 27, 2009
Last updated: March 13, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |